Home Medicine Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases
Article
Licensed
Unlicensed Requires Authentication

Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases

  • Markus Langkamp , Stephanie C. Hörnig , Joachim B. Hörnig , Marion Kirschner , Lutz Pridzun and Malte E. Kornhuber
Published/Copyright: November 1, 2009

Abstract

Background: Multiple sclerosis (MS) is a frequent and often severe autoimmune disease of the central nervous system. We describe a newly developed enzyme-linked immunosorbent assay (ELISA)-based test system for the assessment of neuronal autoantibodies in serum and cerebrospinal fluid (CSF). This tool could help define autoimmune status and thus be a potential means of therapeutic surveillance.

Methods: We used an assay system (ELISA, E100, Mediagnost) based on purified bovine antigens [myelin-oligodendrocyte glycoprotein (MOG), myelin basic protein (MBP), myelin-associated glycoprotein (MAG), proteolipid protein (PLP) and alpha-B-crystalline (CRY)] antibodies for the measurement of specific immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies. Assay characteristics and preliminary validation were conducted by measurement of serum and CSF samples from 41 MS patients and 128 patients with other neurological diseases (OND).

Results: We measured the inter- (17.8/10.1%) and intra-assay variability (5.5/6.7%); linearity (1:250– 1:16,000), and specificity of IgG and IgM. We demonstrate that by the results of this test system MS patients can be differentiated from patients with OND.

Conclusions: The ELISA kit we evaluated is suitable for the measurement of neuronal autoantibodies. The initial validation demonstrates its potential use in the differential diagnosis of central neuronal system diseases.

Clin Chem Lab Med 2009;47:1395–400.


Corresponding author: Markus Langkamp, Mediagnost GmbH, Aspenhaustr. 25, 72770 Reutlingen, Germany Phone: +49 7121 51 484 0, Fax: +49 7121 51 484 10,

Received: 2009-5-28
Accepted: 2009-7-28
Published Online: 2009-11-01
Published in Print: 2009-11-01

©2009 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. The journal impact factor: navigating between Scylla and Charybdis
  3. Opinion Papers
  4. Journal Impact Factor: it will go away soon
  5. The Journal Impact Factor: don't expect its demise any time soon
  6. Reviews
  7. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem?
  8. Molecular diagnostics in acute leukemias
  9. Opinion Paper
  10. Considerations for the development of a reference method for sequencing of haploid DNA – an opinion paper on behalf of the IFCC Committee on Molecular Diagnostics. International Federation of Clinical Chemistry and Laboratory Medicine
  11. General Clinical Chemistry and Laboratory Medicine
  12. Meta-analyses of diagnostic studies
  13. Development and implementation of an automatic system for verification, validation and delivery of laboratory test results
  14. Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye?
  15. Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis
  16. Serum albumin fragmentation in end-stage renal disease patients – a pilot study
  17. Enhanced bone metabolism in vegetarians – the role of vitamin B12 deficiency
  18. Impaired anti-inflammatory function of apolipoprotein A-II concentrations predicts metabolic syndrome and diabetes at 4 years follow-up in elderly Turks
  19. Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases
  20. The rate of manual peripheral blood smear reviews in outpatients
  21. Markers of infection in inpatients and outpatients with acute Q-fever
  22. Validation and Outcome Studies
  23. Potential utility of the new Sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism
  24. A new turbidimetric method for assaying serum C-reactive protein based on phosphocholine interaction
  25. Potential of the Sebia Capillarys® neonat fast automated system for neonatal screening of sickle cell disease
  26. Biochemical role of intravaginal sildenafil citrate as a novel antiabortive agent in unexplained recurrent spontaneous miscarriage: first clinical study of four case reports from Egypt
  27. Cancer Diagnostics
  28. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer – evaluation of the prognostic significance of these agents
  29. Letters to the Editor
  30. Quick and easy colorimetric test for calibration control of liquid handling workstations
  31. GSTP1*B allele increases the risk for asthma in children
Downloaded on 9.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2009.313/html
Scroll to top button